| CTRI Number |
CTRI/2025/12/099529 [Registered on: 19/12/2025] Trial Registered Prospectively |
| Last Modified On: |
18/12/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
Pain relief after kidney stone surgery: A study comparing ultrasound guided erector spinae block with peritubal infiltration. |
|
Scientific Title of Study
|
A Comparision of ultrasound guided erector spinae plane blocks versus peritubal infiltration for poatoperative analgesia in percutaneous nephrolithotomy. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| Nil |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr. Margesh Bharatbhai Thakkar |
| Designation |
2nd Year Resident Of MD Anaesthesiology |
| Affiliation |
B.J. MEDICAL COLLEGE,CIVIL Hospital,Ahmedabad |
| Address |
F3, first floor Department of Anesthesiology, trauma building ,civil hospital, asarwa, Haripura, Ahmedabad. F3, first floor Department of Anesthesiology, trauma building ,civil hospital, asarwa, Haripura Ahmedabad. Ahmadabad GUJARAT 380016 India |
| Phone |
8511777540 |
| Fax |
|
| Email |
tmargesh15@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Siddharthkumar B Parmar |
| Designation |
MD A naesthesiology |
| Affiliation |
B.J. MEDICAL COLLEGE,CIVIL Hospital,Ahmedabad |
| Address |
F3, first floor Department of Anaesthesia , trauma building ,civil hoaspital campus, asarwa, haripura ahmedabad.
Ahmadabad GUJARAT 380016 India |
| Phone |
9426332701 |
| Fax |
|
| Email |
drsid25@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Siddharthkumar B Parmar |
| Designation |
MD A naesthesiology |
| Affiliation |
B.J. MEDICAL COLLEGE,CIVIL Hospital,Ahmedabad |
| Address |
F3, first floor Department of Anaesthesia , trauma building ,civil hoaspital campus, asarwa, haripura ahmedabad.
Ahmadabad GUJARAT 380016 India |
| Phone |
9426332701 |
| Fax |
|
| Email |
drsid25@gmail.com |
|
|
Source of Monetary or Material Support
|
| Goverment of Gujarat Health and family welfare department 7th floor new sachivalaya Gandhinagar 382010 Gujarat India |
|
|
Primary Sponsor
|
| Name |
Goverment of Gujarat |
| Address |
Health and family welfare department 7th floor new sachivalaya Gandhinagar 382010 Gujarat India |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Margesh Bharatbhai Thakkar |
BJ Medical college and civil hospital |
Urology operation theatre, 04 wing 1200 bed hospital, Anesthesia Department Ahmadabad GUJARAT |
8511777540
tmargesh15@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| The Institutional Ethics Committee B.J. Medical College Civil hospital Ahmedabad |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: N289||Disorder of kidney and ureter, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Inj Ropivacaine given in erector spinae plane in postoperative period |
Inj Ropivacaine 0.25% total 20 given in erector spinae plane block for postoperative analgesia |
| Comparator Agent |
Injection Ropivacaine given for peritubal infiltration. In postoperative period. |
Injection Ropivacaine 0.25% total 20 ml given for peritubal infiltration for postoperative analgesia. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
ASA grade I, II, III undergoing elective surgery under general anesthesia.
Patient having unilateral renal stone who is undergoing for PCNL
willingness of patient.
|
|
| ExclusionCriteria |
| Details |
ASA grade IV,V.
Patient having bilateral renal stone.
Contraindication to giving block.
Patient having neuromuscular disorder and neurological symptoms.
Pregnancy.
Patient giving negative consent for procedure. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
On-site computer system |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To compare the duration of analgesia. |
To compare duration of analgesia, in first 24 hours. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To monitor and compare the incidence of adverse effect. |
Postoperative 24 hours. |
| To assess postoperative hemodynamic parameter in both groups. |
Postoperative 24 hours. |
|
|
Target Sample Size
|
Total Sample Size="59" Sample Size from India="59"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/01/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
01/01/2026 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="10" Days="25" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Analytic Code
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response (Others) -
- For how long will this data be available start date provided 01-10-2026 and end date provided 01-10-2031?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - Nil
|
|
Brief Summary
|
Postoperative pain management after PCNL is important as patient have more pain after PCNL. Erector spinae plane blocks provide more pain relief after procedure with injection Ropivacaine 0.25%. |